Report Scope:
This report offers a detailed picture of the acne drug market. It highlights the current and future market potential for acne drugs and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities, and trends in the market. The report also covers market projections through 2025 as well as key market players.
This report details market shares for acne drugs based on drug type, route of administration, distribution channel, and geography. Based on drug type, the market is segmented into the retinoid, antibiotics, hormonal agent, and other segments. Based on the route of administration, the market is segmented into topical and oral. Based on the distribution channel, the market segmented into prescription-based and over the counter (OTC).
By geography, the market has been segmented into North and South America, Europe, Asia-Pacific, and the Middle East and Africa. Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China, and India) are covered in regional segments. For market estimates, data have been provided for 2020 as the base year, with forecasts for 2020 through 2025. Estimated values are based on drug manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
The Report Includes:
- 33 data tables and 21 additional tables
- An overview of the global acne drugs market
- Estimation of the market size and analyses of global market trends, with data from 2018 and 2019, estimated data for 2020, and projections of compound annual growth rates (CAGRs) through 2025
- Highlights of current and future market potential, market size, and market share analysis based on drug type, mode of administration, distribution channel, and region
- Analysis of market trends and explanation of factors driving and restraining the growth of the global acne drugs market
- Discussion on the impact of coronavirus on the global economy and information on government expenditures on COVID-19
- Coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and new product launches in the market
- Comprehensive company profiles of major players of the industry, including Allergan, Bausch Health, Galderma, GlaxoSmithKline PLC, and Pfizer Inc.
Table of Contents
Chapter 1 Introduction
- Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst's Credentials
- Custom Research
- Related Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
- Overview of Acne Drugs
- Comedonal
- Papulopustular
- Nodulocystic
- History of Outbreaks
- Regulatory Scenario
- Regulations in the U.S.
Chapter 4 Economic Impact of COVID-19
- Impact of COVID-19 on the Global Economy
- Government Expenditures on COVID-19
- Impact of COVID-19 on Pharma Supply Chains
- Disruption of Clinical Trials
- Impact on Insurance Providers
- Impact on Health Technology Assessment
- The threat to Healthcare Acquisitions
Chapter 5 Market Dynamics
- Market Drivers
- Overview
- Increasing Prevalence of Acne and Facial Skin Diseases
- Unhealthy Eating Habits and Lifestyles Worldwide
- Rise in Adoption of Skin Care Products
- Growing Acne Cases in Geriatric Population
- Market Restraints
- Side Effects Associated with Medication
- Presence of Alternatives for Acne Treatment
- Market Opportunities
- Unmet Needs in Low- and Middle-Income Countries
- Macroeconomic Indicators
Chapter 6 Market Factor Analysis
- Porter's Five Forces Model
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- The threat of New Entrants
- Threat of Substitutes
- Intensity of Rivalry
- Value Chain Analysis
- R&D
- Clinical Testing
- Manufacturing
- Marketing and Sales
- Post-Sales Services
Chapter 7 Market Breakdown by Drug Type
- Global Market for Acne Drugs by Drug Type
- Retinoid
- Market Size and Forecast
- Antibiotics
- Market Size and Forecast
- Hormonal Agents
- Market Size and Forecast
- Others
- Market Size and Forecast
Chapter 8 Market Breakdown by Route of Administration
- Global Market for Acne Drugs by Route of Administration
- Topical
- Market Size and Forecast
- Oral
- Market Size and Forecast
Chapter 9 Market Breakdown by Distribution Channel
- Global Market for Acne Drugs by Distribution Channel
- Over-the-Counter
- Market Size and Forecast
- Prescription Based
- Market Size and Forecast
Chapter 10 Market Breakdown by Region
- Global Market for Acne Drugs by Region
- North and South America
- United States
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East and Africa
- Market Size and Forecast
Chapter 11 Competitive Landscape
- Global Company Ranking
- Global Acne Drug Market Insights
Chapter 12 Company Profiles
- Allergan
- Bausch Health Companies Inc.
- F. Hoffmann-La Roche Ltd.
- Galderma
- Glaxosmithkline Plc
- Mylan N.V.
- Pfizer Inc.
- Perrigo
- Teva Pharmaceutical Industries Ltd.
List of Tables
Summary Table A: Global Market for Acne Drugs, by Drug Type, Through 2025
Summary Table B: Global Market for Acne Drugs, by Route of Administration, Through 2025
Table 1: Drugs Generally Prescribed for Acne Patients
Table 2: Acne Drug Categories
Table 3: Interim Economic Outlook Forecasts, by Country/Region, March 2, 2021
Table 4: Expenditures on COVID-19 Crisis
Table 5: Disruptions of Clinical Trials Due to COVID-19, by Therapeutic Area
Table 6: Global Market for Acne Drugs, by Drug Type, Through 2025
Table 7: Different Types of Retinoids and their Effects
Table 8: Global Market for Retinoid for Acne, by Region, Through 2025
Table 9: Global Market for Antibiotics for Acne, by Region, Through 2025
Table 10: Global Market for Hormonal Agents for Acne, by Region, Through 2025
Table 11: Global Market for Other Drugs for Acne, by Region, Through 2025
Table 12: Global Market for Acne Drugs, by Route of Administration, Through 2025
Table 13: Global Market for Acne Drugs for Topical Administration, by Region, Through 2025
Table 14: Global Market for Acne Drugs for Oral Administration, by Region, Through 2025
Table 15: Global Market for Acne Drugs, by Distribution Channel, Through 2025
Table 16: Global Market for Over-the-Counter Acne Drugs, by Region, Through 2025
Table 17: Global Market for prescription-based Acne Drugs, by Region, Through 2025
Table 18: Global Market for Acne Drugs, by Region, Through 2025
Table 19: North and South American Market for Acne Drugs, by Drug Type, Through 2025
Table 20: North American Market for Acne Drugs, by Country, Through 2025
Table 21: European Market for Acne Drugs, by Drug Type, Through 2025
Table 22: European Market for Acne Drugs, by Country, Through 2025
Table 23: Asia-Pacific Market for Acne Drugs, by Drug Type, Through 2025
Table 24: Asia-Pacific Market for Acne Drugs, by Country, Through 2025
Table 25: Middle Eastern and African Market for Acne Drugs, by Drug Type, Through 2025
Table 26: Global Company Ranking Analysis in the Market for Acne Drugs, 2019
Table 27: Recent Developments in the Market for Acne Drugs
Table 28: Major Manufacturing Sites of Allergan
Table 29: Allergan: Financials, 2017-2019
Table 30: Allergan: Product Portfolio
Table 31: Allergan: Recent Developments, March 2018-April 2020
Table 32: Bausch Health Companies Inc.: Financials, 2017-2019
Table 33: Bausch Health Companies Inc.: Revenue, by Business Segment, 2017-2019
Table 34: Bausch Health Companies Inc.: Product Portfolio
Table 35: Bausch Health Companies Inc.: Recent Developments, October 2018-April 2020
Table 36: F. Hoffmann-La Roche Ltd.: Financials, 2019
Table 37: F. Hoffmann-La Roche Ltd.: Revenue, by Business Segment, 2016-2018
Table 38: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 39: Galderma: Products Overview
Table 40: Galderma: Recent Developments, April 2015-April 2020
Table 41: GlaxoSmithKline PLC: Financials, 2017-2019
Table 42: GlaxoSmithKline PLC: Products and Services
Table 43: Mylan N.V.: Financial Performance, 2018 and 2019
Table 44: Mylan N.V.: Product Portfolio
Table 45: Pfizer Inc.: Financials, 2017-2019
Table 46: Pfizer Inc.: Products and Services
Table 47: Perrigo: Key Products
Table 48: Perrigo: Financials, 2017-2019
Table 49: Perrigo: Recent Developments, March 2020
Table 50: Teva Pharmaceutical Industries Ltd.: Product Portfolio
Table 51: Teva Pharmaceutical Industries Ltd.: Financials, 2017-2019
Table 52: Teva Pharmaceutical Industries Ltd.: Recent Developments, August 2015-March 2020
List of Figures
Summary Figure A: Global Market for Acne Drugs, by Drug Type, 2018-2025
Summary Figure B: Global Market Shares of Acne Drugs, by Route of Administration, 2019
Figure 1: Comparison of GDP Growth, by Country, 2019 and 2020
Figure 2: Distribution of the Disruption of Clinical Trials Due to COVID-19, by Therapeutic Area
Figure 3: Acne Vulgaris Patients, by Age Group
Figure 4: Global Market Shares of Acne Drugs, by Drug Type, 2019
Figure 5: Global Market for Retinoid Acne Drugs, 2019-2025
Figure 6: Global Market for Retinoid for Acne, by Region, 2018-2025
Figure 7: Global Market for Antibiotics for Acne, 2019-2025
Figure 8: Global Market for Antibiotics for Acne, by Region, 2018-2025
Figure 9: Global Market for Hormonal Agents for Acne, 2019-2025
Figure 10: Global Market for Hormonal Agents for Acne, by Region, 2018-2025
Figure 11: Global Market for Other Drugs for Acne, 2019-2025
Figure 12: Global Market for Other Drugs for Acne, by Region, 2018-2025
Figure 13: Global Market Shares of Acne Drugs, by Route of Administration, 2019
Figure 14: Global Market for Acne Drugs for Topical Administration, 2019-2025
Figure 15: Global Market for Acne Drugs for Topical Administration, by Region, 2018-2025
Figure 16: Global Market for Acne Drugs for Oral Administration, 2019-2025
Figure 17: Global Market for Acne Drugs for Oral Administration, by Region, 2018-2025
Figure 18: Global Market Shares of Acne Drugs, by Distribution Channel, 2019
Figure 19: Global Market for Over-the-Counter Acne Drugs, 2019-2025
Figure 20: Global Market for Over-the-Counter Acne Drugs, by Region, 2018-2025
Figure 21: Global Market for Prescription-Based Acne Drugs, 2019-2025
Figure 22: Global Market for Prescription-Based Acne Drugs, by Region, 2018-2025
Figure 23: Global Market Shares of Acne Drugs, by Region, 2019
Figure 24: North and South America Market Shares of Acne Drugs, by Drug Type, 2019
Figure 25: North America Market Shares of Acne Drugs, by Country, 2019
Figure 26: U.S. Market for Acne Drugs, 2019-2025
Figure 27: Canadian Market for Acne Drugs, 2019-2025
Figure 28: European Acne Drug Market Shares, by Drug Type, 2019
Figure 29: European Market Shares of Acne Drugs, by Country, 2019
Figure 30: German Market for Acne Drugs, 2019-2025
Figure 31: U.K. market for Acne Drugs, 2019-2025
Figure 32: French Market for Acne Drugs, 2019-2025
Figure 33: Italian Market for Acne Drugs, 2019-2025
Figure 34: Spanish Market for Acne Drugs, 2019-2025
Figure 35: Rest of European Market for Acne Drugs, 2019-2025
Figure 36: Asia-Pacific Market Shares of Acne Drugs, by Drug Type, 2019
Figure 37: Asia-Pacific Market Shares of Acne Drugs, by Country, 2019
Figure 38: Chinese Market for Acne Drugs, 2019-2025
Figure 39: Indian Market for Acne Drugs, 2019-2025
Figure 40: Japanese Market for Acne Drugs, 2019-2025
Figure 41: Australian Market for Acne Drugs, 2019-2025
Figure 42: South Korean Market for Acne Drugs, 2019-2025
Figure 43: Rest of Asia-Pacific Market for Acne Drugs, 2019-2025
Figure 44: Middle Eastern and African Market for Acne Drugs, 2019-2025
Figure 45: Middle Eastern and African Market Shares of Acne Drugs, by Drug Type, 2019
Figure 46: Allergan: Revenue Share, by Business Unit, 2019
Figure 47: Allergan: Revenue Share, by Region, 2019
Figure 48: Bausch Health Companies Inc.: Revenue Share, by Business Segment, 2019
Figure 49: F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Segment, 2019
Figure 50: F. Hoffmann-La Roche Ltd.: Revenue Share, by Region, 2019
Figure 51: GlaxoSmithKline PLC: Revenue Share, by Business Segment, 2019
Figure 52: GlaxoSmithKline PLC: Revenue Share, by Region, 2019
Figure 53: Mylan N.V.: Revenue Share, by Region, 2019
Figure 54: Pfizer Inc.: Revenue Share, by Business Segment, 2019
Figure 55: Pfizer Inc.: Revenue Share, by Region, 2019
Figure 56: Perrigo: Revenue Share, by Business Segment, 2019
Figure 57: Teva Pharmaceutical Industries Ltd.: Revenue Share, by Region, 2019
Samples
LOADING...
Companies Mentioned
- Allergan
- Bausch Health Companies Inc.
- F. Hoffmann-La Roche Ltd.
- Galderma
- Glaxosmithkline Plc
- Mylan N.V.
- Perrigo
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
